関連する実験動画
Updated: Feb 17, 2026

05:14
A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
5.4K
枢軸症状として心不全を呈するアクロメガリー誘発の拡張性心筋症候群:症例報告
Jiamin Xu1, Jie Liu1, Heng Wu1
1Cardiovascular Disease Center, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi Clinical College of Wuhan University, China.
SAGE open medical case reports
|February 16, 2026
まとめ
成長ホルモンの障害であるアクロメガリーは,アクロメガリック心筋症候群による心不全を引き起こす可能性があります. この症例報告は,この深刻な状態につながった下垂体腺腫を詳細に説明しています.
科学分野:
- エンドクリノロジー エンドクリノロジー
- 心臓病学 心臓病学
- 腫瘍学 腫瘍学
背景:
- アクロメガリーは,過剰な成長ホルモン (GH) とインスリン類似成長因子-1 (IGF-1) の上昇によって引き起こされる珍しい内分泌障害です.
- それは,心筋病,心律不全,心不全を含む心血管合併症のリスクを大幅に増加させます.
- アクロメガリック心筋症は,罹患した患者の死亡の主な原因です.
研究 の 目的:
- アクロメガリック心筋症の症例報告を提出する.
- pituitary adenomasと心臓の合併症の間のリンクを強調するために.
主な方法:
- 53歳の男性患者の症例報告です.
- 下垂体腺腫に二次的なアクロメガル性心筋病症の診断.
主要な成果:
- 患者は,アクロメガル性心筋症候群と診断されました.
- 根本的な原因は,下垂体腺腫として特定されました.
結論:
- 下垂体腺腫は,アクロメガル性心筋病および心不全を引き起こす可能性があります.
- アクロメガリーの早期診断と管理は,心血管疾患による死亡率を予防するために極めて重要です.
キーワード:
アクロメガリック心筋病変症ケースレポート ケースレポート成長ホルモンの成長ホルモンは,心不全とは,心不全である.pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma pituitary adenoma関連する概念動画
Cardiomyopathy II: Dilated Cardiomyopathy
594
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
594
Cardiomyopathy III: Hypertrophic Cardiomyopathy
539
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
539
Cardiomyopathy V: Interprofessional Care
483
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
483
Heart Failure III: Clinical Manifestations
648
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
648
Mitral Regurgitation I: Introduction
642
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
642
Heart Failure I: Introduction
969
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
969

